El Salvador

Committee of the Whole L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs

Secretariat: There will be an informal on L5 in a hybrid format on BR-A. L7 – Technical amendment. On OP12 & 13 – There is in square brackets ‘or trafficking’. There was an omission to delete this part. Just checking with the CoW. Ok, we can continue. United States: We engaged in consultations, not in …

Read more

Plenary Item 5. Implementation of the international drug control treaties

(a) Changes in the scope of control of substances Chair: We resume considerations of Item 5, especially item 5.a. CND is called to perform its treaty mandated function related to scheduling. CND Secretariat: Pre-session documentation is available online. Including scheduling recommendations by the WHO-ECDD. Chair: First, we’ll consider scheduling recommendations on substances under 1961, then …

Read more

Plenary – Agenda item 3: General Debate (continued)

Chair: Because of technical difficulties, we will not start with the Global Fund, so we will start with speakers left from yesterday. Please, limit your statements to 3 minutes. Kazakhstan: CND offers a unique platform to share information and strengthen cooperation. Weve all seen negative trends. This requires continued improvement and focused efforts. Important to …

Read more

Side event: Procurement, Pricing, and Access to Controlled Medicines During COVID-19

Organized by the International Association for Hospice and Palliative Care with the support of Australia, Belgium, and Dejusticia, Harm Reduction International, the Office of the High Commissioner for Human Rights, and the World Health Organization Participants: Ambassador Ghislain D’Hoop, Ambassador of Belgium to the UN organizations Vienna Dr. Zukiswa Zingela, INCB Dr. Tlaleng Mofokeng, UN …

Read more